Rixensart, Belgium

Ralph Leon Biemans

USPTO Granted Patents = 33 

 

 

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 307(Granted Patents)


Company Filing History:


Years Active: 2010-2023

Loading Chart...
Loading Chart...
Loading Chart...
33 patents (USPTO):Explore Patents

Title: Ralph Leon Biemans: Innovator in Pneumococcal Vaccine Development

Introduction

Ralph Leon Biemans, based in Rixensart, Belgium, is a prolific inventor recognized for his significant contributions to the field of vaccine development. With an impressive portfolio of 33 patents, Biemans has established himself as an innovative force in the healthcare sector, particularly in the area of pneumococcal capsular saccharide conjugate vaccines.

Latest Patents

Ralph's latest inventions include a patent focused on pneumococcal capsular saccharide conjugate vaccines, specifically emphasizing serotype 6A capsular polysaccharides. This invention relates to capsular polysaccharides with an average size between 100-1000 kDa, suitably conjugated to a carrier protein. Another notable invention involves an immunogenic composition designed for infants, comprising a multivalent vaccine that includes capsular saccharide conjugates from various serotypes, including a serotype 22F saccharide conjugate. These vaccines aim to reduce the incidence of elderly pneumococcal disease, such as exacerbations of COPD and invasive pneumococcal disease (IPD).

Career Highlights

Ralph Leon Biemans works at GlaxoSmithKline Biologicals SA, a leading company in the development of pharmaceutical products that improve health. His work in vaccine innovation contributes significantly to public health, especially in protecting vulnerable populations such as infants and the elderly.

Collaborations

During his career, Ralph has collaborated with notable colleagues, including Jan Poolman and Pierre Duvivier. Such partnerships enhance the research and development process, combining expertise to foster groundbreaking advancements in vaccine technology.

Conclusion

Ralph Leon Biemans's remarkable contributions to vaccine innovation demonstrate his commitment to improving public health through scientific advancement. With a solid patent portfolio and strategic collaborations, he continues to lead the way in the fight against pneumococcal disease, making a profound impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…